Fortress Biotech, Inc.
FBIO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $86 | $74 | $91 | $57 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $18 | $16 | $18 | $10 |
| Inventory | $12 | $13 | $12 | $14 |
| Other Curr. Assets | $2 | $7 | $5 | $8 |
| Total Curr. Assets | $119 | $110 | $127 | $90 |
| Property Plant & Equip (Net) | $15 | $16 | $16 | $17 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $29 | $30 | $31 | $32 |
| Long-Term Investments | $0 | $1 | $0 | $2 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $19 | $3 | $4 | $3 |
| Total NC Assets | $63 | $49 | $51 | $54 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $181 | $160 | $178 | $144 |
| Liabilities | – | – | – | – |
| Payables | $19 | $20 | $28 | $32 |
| Short-Term Debt | $8 | $6 | $4 | $3 |
| Tax Payable | $1 | $1 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $27 | $30 | $41 | $36 |
| Total Curr. Liab. | $54 | $58 | $74 | $71 |
| LT Debt | $61 | $63 | $70 | $73 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $2 | $2 | $2 |
| Total NC Liab. | $62 | $65 | $72 | $74 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $15 | $15 | $16 | $17 |
| Total Liabilities | $116 | $123 | $146 | $146 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$730 | -$736 | -$751 | -$741 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $786 | $780 | $774 | $764 |
| Total Equity | $56 | $44 | $22 | $23 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $9 | -$7 | $10 | -$24 |
| Total Liab. & Tot. Equity | $181 | $160 | $178 | $144 |
| Net Debt | -$18 | -$5 | -$17 | $19 |